Skip to content

Bill Schiffner

Noninvasive exams can help head off liver disease

Noninvasive exams can help head off liver disease

A race is under way among pharmaceutical companies to develop drugs that treat a spectrum of liver diseases, including nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and its more severe form, nonalcoholic steatohepatitis (NAS